noom glp 1 microdosing Unboxing GLP-1ᴿˣ Noom’s New Microdose GLP-1 Program

Maximum eligibility across every pathway

Weight changes can be influenced by appetite signals, blood sugar patterns, sleep quality, stress load, and the way your body responds to routine over time

GLP-1 medications are not just for people with diabetes

If results remain flat after 8 weeks of dose escalation or compound switch, your Precision Peptide Genetic Test results become invaluable, revealing whether your specific genetic profile suggests an alternative peptide pathway (like MC4R or GIPR variants) that might respond better to a customized approach

Within islet cells, GLP-1RAs activate adenylate cyclase to increase the production of intracellular cyclic adenosine monophosphate (cAMP) and to start the subsequent signaling cascade (Figure 1) [28]